These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 2482063

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42. The in-vitro response of CD2-positive acute myelogenous leukemia to proliferation and differentiation inducing agents.
    Traweek ST, Ben-Ezra J, Braziel RM, Winberg CD.
    Leuk Res; 1990; 14(5):433-40. PubMed ID: 1693168
    [Abstract] [Full Text] [Related]

  • 43. Lineage commitment in biphenotypic acute leukemia.
    Buccheri V, Matutes E, Dyer MJ, Catovsky D.
    Leukemia; 1993 Jun; 7(6):919-27. PubMed ID: 8501986
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. Characterization of acute myeloid leukemia (AML) coexpressing lymphoid markers: different biologic features between T-cell antigen positive and B-cell antigen positive AML.
    Tien HF, Wang CH, Chen YC, Shen MC, Lin DT, Lin KH.
    Leukemia; 1993 May; 7(5):688-95. PubMed ID: 8483320
    [Abstract] [Full Text] [Related]

  • 46. Rearrangement of immunoglobulin and T cell antigen receptor genes in acute myeloid leukemia with lymphoid-associated markers.
    Norton JD, Campana D, Hoffbrand AV, Janossy G, Coustan-Smith E, Jani H, Yaxley JC, Prentice HG.
    Leukemia; 1987 Nov; 1(11):757-61. PubMed ID: 3500372
    [Abstract] [Full Text] [Related]

  • 47. [The immunophenotypic and clinical characteristics of NPM1 mutated acute myeloid leukemia patients].
    Liu YR, Chang Y, Ruan GR, Qin YZ, Lai YY, Shi HX, Wang YZ, Li LD, Jiang B, Li JL.
    Zhonghua Xue Ye Xue Za Zhi; 2013 Feb; 34(2):98-103. PubMed ID: 23611213
    [Abstract] [Full Text] [Related]

  • 48. Expression of NK and lymphoid-associated antigens in blast cells of acute myeloblastic leukemia.
    Vidriales MB, Orfao A, González M, Hernández JM, López-Berges MC, García MA, Cañizo MC, Caballero MD, Macedo A, Landolfi C.
    Leukemia; 1993 Dec; 7(12):2026-9. PubMed ID: 7504772
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. CD7 false-positive acute myelogenous leukemia and promyelocytic leukemia cell line HL-60: characterization of CD7 epitopes by four monoclonal antibodies.
    Imamura N, Ota H, Kuramoto A.
    Am J Hematol; 1991 Sep; 38(1):72-4. PubMed ID: 1716852
    [Abstract] [Full Text] [Related]

  • 51. Putative normal counterparts of leukaemic cells from CD7-positive acute myeloid leukaemia can be demonstrated in human haemopoietic tissues.
    Tien HF, Chou CC, Wang CH, Chang CH, Hsing CC.
    Br J Haematol; 1996 Sep; 94(3):501-6. PubMed ID: 8790149
    [Abstract] [Full Text] [Related]

  • 52. [Analysis of immunophenotype and leukemia associated immunophenotype in 610 patients with acute myeloid leukemia].
    Liu YR, Wang YZ, Chen SS, Chang Y, Fu JY, Li LD, Wang H, Yu H, Jiang B, Huang XJ.
    Zhonghua Xue Ye Xue Za Zhi; 2007 Nov; 28(11):731-6. PubMed ID: 18457262
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Gene rearrangement in acute non-lymphoblastic leukaemia: correlation with morphological and immunophenotypic characteristics of blast cells.
    Sánchez I, San Miguel JF, Corral J, Martín C, Pérez R, González M, Cañizo MC, Orfao A, González-Sarmiento R.
    Br J Haematol; 1995 Jan; 89(1):104-9. PubMed ID: 7530475
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Early expression of MCS2 (CD13) in the cytoplasm of blast cells from acute myeloid leukaemia.
    Pombo de Oliveira MS, Matutes E, Rani S, Morilla R, Catovsky D.
    Acta Haematol; 1988 Jan; 80(2):61-4. PubMed ID: 2901804
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. Naturally selected CD7 CAR-T therapy without genetic editing demonstrates significant antitumour efficacy against relapsed and refractory acute myeloid leukaemia (R/R-AML).
    Lu Y, Liu Y, Wen S, Kuang N, Zhang X, Li J, Wang F.
    J Transl Med; 2022 Dec 14; 20(1):600. PubMed ID: 36517851
    [Abstract] [Full Text] [Related]

  • 59. [Immunophenotype and P-glycoprotein expression in CD7 positive adult acute myeloid leukemia].
    Hua D, Li J, Xia X.
    Zhonghua Xue Ye Xue Za Zhi; 1999 Feb 14; 20(2):88-90. PubMed ID: 11601207
    [Abstract] [Full Text] [Related]

  • 60. Clinical relevance of immunophenotypic and immunogenotypic analysis in acute non-lymphoblastic leukaemia.
    Papadopoulos KP, Bagg A, Bezwoda WR, Mendelow BV.
    S Afr Med J; 1989 Oct 07; 76(7):335-8. PubMed ID: 2552592
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.